# Is It Too Late for Hormone Therapy After Menopause? | Rachel Rubin, M.D.

**Channel:** Peter Attia MD
**Upload Date:** 2025-05-16
**URL:** https://www.youtube.com/watch?v=KiZ7KauLOfQ
**Duration:** 11 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/4iVBpHX
Watch the full episode: https://youtu.be/W0XW6av2wLQ
Become a member to receive exclusive content: https://bit.ly/4iP5ZmE

This clip is from episode 348 ‒ Women’s sexual health, menopause, and hormone replacement therapy (HRT) | Rachel Rubin, M.D.

In this clip, they discuss:

- It’s Not Too Late After Menopause – Why starting hormone therapy after age 60 can still offer major benefits
- Challenging the Timing Hypothesis – New research questions old fears about HRT risks in older women
- Every Woman Deserves the Full Menu – Education, not fear, should guide menopause care and hormone therapy decisions
- Bone, Brain, and Bladder Health – Why hormones are about far more than hot flashes or fertility
- Shared Decision-Making Matters – Women deserve doctors who empower them with real choices, not outdated rules

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's my analysis of this clip from The Drive podcast:

1. **Executive Summary**:
This episode features Dr. Rachel Rubin discussing hormone therapy (HRT) in post-menopausal women. The conversation focuses on three main controversial topics: starting HRT "late" after menopause, duration of therapy, and HRT in women with breast cancer risk. Dr. Rubin challenges several conventional beliefs about HRT, advocating for a more nuanced, individualized approach based on current evidence rather than outdated fears.

2. **Key Medical/Scientific Points**:
- The "timing hypothesis" regarding HRT initiation after age 60 is being questioned by recent research [00:00:30]
- Bone density gains from HRT are lost when therapy is discontinued [00:02:44]
- Three main indications for HRT: vasomotor symptoms, osteoporosis prevention, and genitourinary syndrome of menopause [00:01:30]
- Vaginal estrogen or DHEA is safe throughout life for preventing UTIs [00:02:00]

3. **Health Optimization Tips**:

Universal Recommendations:
- Consider vaginal estrogen or DHEA for UTI prevention regardless of age [00:02:00]
- Don't arbitrarily stop HRT if it's working well [00:02:44]

Context-specific Recommendations:
- Women with DCIS who aren't on endocrine therapy can consider HRT [00:05:20]
- Individual risk-benefit assessment needed for breast cancer patients [00:05:20]

4. **Supplements & Medications**:
- Premarin (mentioned in historical context) [00:00:30]
- Vaginal estrogen [00:02:00]
- DHEA [00:02:00]

7. **Biomarkers & Testing**:
- Bone density measurements (implied in discussion) [00:02:44]

8. **References & Resources**:
- Susan Davis's paper questioning timing hypothesis [00:00:30]
- "Estrogen Matters" book by Avrum Bluming [00:04:47]
- Dr. Kuren Men - referenced as expert on hormone therapy and breast cancer [00:05:20]

9. **Notable Quotes**:
"Women are more than breast tissue. They are so much more than their cancer risk." [00:08:21]

"When you give women information about how their bodies work, they make great decisions for themselves." [00:09:01]

10. **Follow-up Questions**:
- What specific biomarkers should be monitored during HRT?
- What are the latest studies on HRT and cardiovascular outcomes?
- How does the risk-benefit profile change with different delivery methods of HRT?

The other sections (Exercise & Movement, Nutrition & Diet) were not specifically addressed in this clip.
